TrialBlood advances2025

Atezolizumab consolidation in patients with high-risk diffuse large B-cell lymphoma in complete remission after R-CHOP.

Marcel Nijland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.